CalciMedica Inc CALC

Healthcare Biotechnology

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

NDAQ:CALC - Post by User

CalciMedica Inc

<< Previous

Bullboard Posts

Next >>

(11)
•••

Post by alphaflighton May 10, 2022 10:10am

323 Views

Post# 34670129

Graycliff Exploration Booth 301 VRIC Vancouver, May 17-18

Graycliff Exploration Invites Shareholders and Investment Community to Visit Us at Booth 301 at the VRIC in Vancouver, May 17-18, 2022

Vancouver, British Columbia--(Newsfile Corp. – May 10, 2022) - Graycliff Exploration Limited (the “Company” or “Graycliff”) (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) would like to cordially invite you to visit us at Booth #301 at the Vancouver Resource Investment Conference (VRIC) to be held at the Vancouver Convention Centre West (1055 Canada Place, Vancouver) on Tuesday, May 17 – Wednesday, May 18, 2022.

Graycliff’s CEO James Macintosh and Director Nicholas Konkin would be there to answer any of the questions related to Company’s Shakespeare and Baldwin Gold Projects near Sudbury, Ontario.

Former Prime Minister of Canada Stephen Harper and Former President of Mexico Felipe Calderon are two of the marquee speakers at the 2022 Resource Investment Conference. The Vancouver Resource Investment Conference (VRIC) will host over 100 international keynote speakers covering the hottest topics in finance, economics and geopolitics and will include a marketplace of 225 investment opportunities in the mining industry, spanning early-stage exploration to advanced producing mines.

For more information and/or to register for the conference, please visit: https://cambridgehouse.com/vancouver-resource-investment-conference.

We look forward to seeing you there.

About Graycliff Exploration Limited

Graycliff Exploration is a mineral exploration company focused on its 1,025 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's Shakespeare Project consists of one crown patented lease, two crown leases and 40 claims on a property associated with the historic Shakespeare Gold Mine, which operated from 1903 to 1907. Graycliff’s Baldwin Project is adjacent to the east and is comprised of 68 claims covering 1,500 hectares. This brings our total land package in the area to 2,525 hectares.